Determinants of multidrug-resistant tuberculosis (MDR-TB) in Belarus

A. Skrahina, H. Hurevich, A. Zalutskaya, E. Sahalchyk, A. Astrauko, S. Hoffner, V. Rusovich, A. Dadu, P. de Colombani, M. Dara, W. Van Gemert, M. Zignol (Minsk, Belarus; Stockholm, Sweden; Copenhagen, Denmark; Geneva, Switzerland)

Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview
Session: MDR- and XDR-TB: epidemiological and public health overview
Session type: Oral Presentation
Number: 201
Disease area: Respiratory infections

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Skrahina, H. Hurevich, A. Zalutskaya, E. Sahalchyk, A. Astrauko, S. Hoffner, V. Rusovich, A. Dadu, P. de Colombani, M. Dara, W. Van Gemert, M. Zignol (Minsk, Belarus; Stockholm, Sweden; Copenhagen, Denmark; Geneva, Switzerland). Determinants of multidrug-resistant tuberculosis (MDR-TB) in Belarus. Eur Respir J 2012; 40: Suppl. 56, 201

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Analysis of multidrug-resistant tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014


Multidrug-resistant tuberculosis (MDR-TB) and HIV co-infection in Romania
Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Year: 2011


Multidrug-resistant tuberculosis (MDR-TB)
Source: Breathe 2010; 6: 283
Year: 2010

The global risk of dying from multidrug-resistant tuberculosis (MDR-TB)
Source: International Congress 2014 – Tuberculosis epidemiology: novel features
Year: 2014

Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk
Source: Eur Respir J 2012; 39: 1425-1431
Year: 2012



Extensively drug-resistant tuberculosis (XDR-TB) and multidrug-resistant tuberculosis (MDR-TB): a retrospective comparative study
Source: Annual Congress 2008 - Multidrug-resistant and the emerging threat of extensively drug-resistant tuberculosis
Year: 2008


Spread of tuberculosis among household contacts of multi drug resistant tuberculosis (MDRTB) patients
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014


Trends of multidrug-resistant tuberculosis clustering in Portugal
Source: ERJ Open Res, 5 (1) 00151-2018; 10.1183/23120541.00151-2018
Year: 2019



Multidrug-resistant tuberculosis in children of Belarus
Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis
Year: 2021


Treatment outcomes for multidrug-resistant tuberculosis (MDR-TB) patients in Africa
Source: Annual Congress 2011 - Multidrug-resistant tuberculosis
Year: 2011

Surgical treatment of multidrug-resistant tuberculosis (MDR TB)
Source: Eur Respir J 2003; 22: Suppl. 45, 523s
Year: 2003

Long-term treatment outcomes in multidrug-resistant tuberculosis (MDR-TB)
Source: Annual Congress 2007 - Drug-resistant and multidrug-resistant tuberculosis
Year: 2007


Facilities for treating multidrug-resistant tuberculosis (MDRTB) in Europe
Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology
Year: 2016



Treatment outcomes and deaths among multidrug-resistant tuberculosis (MDR-TB) patients in Gomel region, Belarus – 2009-2010
Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights
Year: 2013


Prevalence of fluoroquinolon-resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Extensively drug-resistant (XDR) pulmonary tuberculosis in HIV negative cases
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008

Transmission of mycobacterium tuberculosis Ural 163-15 lineage causing multidrug-resistant tuberculosis among hospitalized patients
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015

Risk factors for multidrug-resistant and extensively drug-resistant tuberculosis in Estonia
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008

Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia)
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015

Genotypes and drug resistance patterns of multi-drug-resistant mycobacterium tuberculosis strains in Pakistan
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015